Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong · Delayed Price · Currency is HKD 64.70
+0.35 (0.54%)
At close: Apr 2, 2026
Suzhou Ribo Life Science Revenue
In the year 2025, Suzhou Ribo Life Science had annual revenue of 148.51M CNY with 4.12% growth. Suzhou Ribo Life Science had revenue of 44.70M in the half year ending December 31, 2025.
Revenue
148.51M CNY
Revenue Growth
+4.12%
P/S Ratio
66.77
Revenue / Employee
367.60K CNY
Employees
404
Market Cap
11.03B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 148.51M | 5.88M | 4.12% |
| Dec 31, 2024 | 142.63M | 142.58M | 324,052.27% |
| Dec 31, 2023 | 44.00K | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Billion Industrial Holdings | 20.09B |
| TUHU Car | 18.32B |
| China Datang Corporation Renewable Power | 14.00B |
| Newborn Town | 7.67B |
| Red Star Macalline Group Corporation | 7.31B |
| JNBY Design | 6.42B |
| Mongolian Mining | 6.41B |
| China East Education Holdings | 5.14B |